Home The Big Story When The Trade Desk Dips, Ad Tech Drops

When The Trade Desk Dips, Ad Tech Drops

SHARE:

Investors use The Trade Desk as a proxy for the health of the entire open web advertising ecosystem, which means TTD’s recent run of concerning earnings is devaluing the entire ad tech sector.

Doubts about how TTD is competing with walled gardens like Amazon, along with slower overall revenue growth, have led some investors to downgrade the DSP’s stock from “buy” to “hold.”

Since TTD reported its Q2 earnings last week – including a respectable but slightly underwhelming 19% YOY growth rate – its price per share has been down about 40%.

And other ad tech companies, including Zeta, MNTN, Magnite, PubMatic and Viant, have also seen their stock prices drop despite solid Q2 earnings.

But TTD’s recent issues aside, what’s really turning investors away from ad tech is the seismic shift in online search as new AI-powered platforms restrict referral traffic to open web publishers. That’s according to Laura Martin, managing director of investment firm Needham & Company and our guest on this week’s episode of The Big Story.

“Investors are worried that digital ad dollars are moving into walled gardens, of which Amazon is the one to beat right now,” Martin says. “But, also, there’s a very real concern that suddenly the open internet is not going to get the consumer traffic it used to, which lowers the total addressable market for every company that sells ads on the open internet.”

In other words, some investors see the writing on the wall for the open web. But Martin believes the open web isn’t going anywhere, despite losing ground to Big Tech and social media, where it’s easier to demonstrate how ads perform within their closed ecosystems.

Yet the shifting search landscape is not an excuse for failing to fix the structural issues that led to TTD’s underwhelming Q4, namely the slower-than-expected rollout of its new Kokai platform.

“It feels like the problems that Jeff itemized in the fourth quarter call aren’t fixed, and that’s problematic,” says Martin, referring to TTD CEO Jeff Green.

However, there’s something to be said for the “If you can’t beat ’em, join ’em” mentality, according to Martin. TTD’s best path forward, she says, may just be to become more like the walled garden platforms it reviles by preferencing its direct publisher relationships.

Must Read

Rest In Privacy, Sandbox

Last week, after nearly six years of development and delays, Google officially retired its Privacy Sandbox.
Which means it’s time for a memorial service.

AWS Launches A Cloud Infrastructure Service For Ad Tech

AWS RTB Fabric offers ad tech platforms more streamlined integrations with ecosystem and infrastructure partners, allegedly lower latency compared to the public internet and discounts on data transfers.

Netflix Boasts Its Best Ad Sales Quarter Ever (Again)

In a livestreamed presentation to investors on Tuesday, co-CEO Greg Peters shared that Netflix had its “best ad sales quarter ever” in Q3, and more than doubled its upfront commitments for this year.

Privacy! Commerce! Connected TV! Read all about it. Subscribe to AdExchanger Newsletters
Comic: No One To Play With

Google Pulls The Plug On Topics, PAAPI And Other Major Privacy Sandbox APIs (As The CMA Says ‘Cheerio’)

Google’s aborted cookie crackdown ends with a quiet CMA sign-off and a sweeping phaseout of Privacy Sandbox technologies, from the Topics API to PAAPI.

The Trade Desk’s Auction Evolutions Bring High Drama To The Prebid Summit

TTD shared new details about OpenAds features that let publishers see for themselves whether it’s running a fair auction. But tension between TTD and Prebid hung over the event.

Monopoly Man looks on at the DOJ vs. Google ad tech antitrust trial (comic).

How Google Stands In The DOJ’s Ad Tech Antitrust Suit, According To Those Who Tracked The Trial

The remedies phase of the Google antitrust trial concluded last week. And after 11 days in the courtroom, there is a clearer sense of where Judge Leonie Brinkema is focused on, and how that might influence what remedies she put in place.